Rocket Doctor AI set to present at NIBA conference in Florida

Rocket Doctor AI Inc. will present Oct. 7 at the 153rd National Investment Banking Association conference in Fort Lauderdale, Florida. The company plans to highlight its platform, recent milestones and growth strategy as it looks to connect with investors and financing partners.

Why it matters: - Rocket Doctor AI is using the NIBA conference to pitch its healthcare AI platform to micro-cap and small-cap investment professionals. - The presentation could help the company build visibility with financing partners, market makers and investors ahead of future growth plans.

What happened: - Rocket Doctor AI Inc. will present on Oct. 7, 2026, at the 153rd Investment Conference hosted by the National Investment Banking Association in Fort Lauderdale, Florida. - CEO Dr. Essam Hamza will deliver a high-level overview of the company’s highlights, platform, recent milestones and growth strategy. - Rocket Doctor AI is a B2i Digital Featured Company, with an in-depth profile available here.

The details: - Rocket Doctor AI trades on the CSE under AIDR, on the OTC under AIRDF and in Frankfurt under 939. - The company describes itself as a physician-built, AI-powered healthcare technology company focused on empowering doctors and expanding access to high-quality care. - NIBA is a non-profit organization that has served the micro-cap and small-cap investment community for almost 50 years. - The conference website is available here. - Rocket Doctor AI says its proprietary Global Library of Medicine is a clinically validated decision support system built with input from hundreds of physicians worldwide. - Rocket Doctor Inc. and its AI-powered digital health platform and marketplace have helped empower over 350 MDs to provide care in more than 800,000 patient visits. - The company says its software helps doctors launch and manage virtual or hybrid in-person practices, reduce administrative burdens and improve consistency in care. - Rocket Doctor AI says its technology is aimed at underserved, rural and remote communities in Canada and at patients on Medicaid and Medicare in the United States. - The company says it uses advanced AI, large language models and connected medical devices to make healthcare more scalable, equitable and patient-centered. - Contact information listed in the release includes www.rocketdoctor.ai, info@rocketdoctor.ai, essam.hamza@rocketdoctor.ai, bill@rocketdoctor.io and media@rocketdoctor.ai.

Between the lines: - The presentation underscores how micro-cap healthcare AI companies use investor conferences to frame growth stories and build financing relationships. - The release leans on operational metrics, physician participation and access-to-care claims to position Rocket Doctor AI as both a technology and healthcare access story. - The forward-looking language in the release signals that the presentation and growth strategy remain subject to execution and market risk.

What's next: - Rocket Doctor AI will present at the conference on Oct. 7. - The company expects to use the event to expand conversations with investment professionals, financing partners and market makers. - Any updates on the company’s strategy, platform or commercialization efforts will likely follow future announcements and securities filings.

The bottom line: - Rocket Doctor AI is taking its AI healthcare pitch to investors in Florida as it looks to turn clinical software traction into market momentum.